Concepedia

Robert Schlossman

RS

Statistics

Publications

129

Citations

18.9K

H-Index

68

Active since

1995

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Emory University

University of Michigan

Robert Schlossman is an author at Dana-Farber Cancer Institute specializing in medicine, multiple myeloma, and multiple myeloma therapy.

Publications per year

1995–2022

129

Publications

129

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

Faith E. Davies, Noopur Raje, Teru Hideshima et al. · Blood · 2001 · 905 citations

Medicine, Immunology, Oncology +12

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Paul G. Richardson, Edie Weller, Sagar Lonial et al. · Blood · 2010 · 862 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy

Teru Hideshima, Dharminder Chauhan, Yoshihito Shima et al. · Blood · 2000 · 859 citations

Medicine, Oncology, Pharmacology +16

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

Paul G. Richardson, Robert Schlossman, Edie Weller et al. · Blood · 2002 · 804 citations · Full text

Medicine, Immunology, Pharmacology +12

1–5 of 129